Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(66 sites)
United States
Mayo Clinic Arizona, Scottsdale, Arizona Highlands Oncology Group, Fayetteville, Arkansas Rocky Mountain Cancer Centers, Denver, Colorado Hartford Hospital, Hartford, Connecticut Yale New Haven Hospital, New Haven, Connecticut Mayo Clinic Jacksonville, Jacksonville, Florida Winship Cancer Institute, Atlanta, Georgia St Elizabeth Healthcare, Edgewood, Kentucky LSU Medical Center, New Orleans, Louisiana Henry Ford Hospital, Detroit, Michigan Mount Sinai Medical Center, New York, New York Piedmont Healthcare, Winston-Salem, North Carolina Tennessee Oncology, Nashville, Tennessee TxO Austin Midtown, Austin, Texas Texas Oncology, Dallas, Texas Virginia Cancer Specialists, Fairfax, Virginia Virginia Oncology Associates, Norfolk, Virginia Blue Ridge Cancer Center, Wytheville, Virginia Northwest Medical Specialties, Tacoma, Washington Canada
Novartis Investigative Site, Edmonton, Alberta Novartis Investigative Site, London, Ontario Novartis Investigative Site, Toronto, Ontario Novartis Investigative Site, Montreal, Quebec China
Novartis Investigative Site, Beijing Novartis Investigative Site, Beijing Novartis Investigative Site, Beijing Novartis Investigative Site, Shanghai France
Novartis Investigative Site, Bron Novartis Investigative Site, Clichy Novartis Investigative Site, Montpellier Novartis Investigative Site, Nantes Novartis Investigative Site, Pessac Novartis Investigative Site, Toulouse Germany
Novartis Investigative Site, Erlangen Novartis Investigative Site, Essen Novartis Investigative Site, München Hungary
Novartis Investigative Site, Budapest Novartis Investigative Site, Szeged Italy
Novartis Investigative Site, Cona, FE Novartis Investigative Site, Genova, GE Novartis Investigative Site, Milan, MI Novartis Investigative Site, Rozzano, MI Novartis Investigative Site, Pisa, PI Novartis Investigative Site, Roma, RM Novartis Investigative Site, Roma, RM Novartis Investigative Site, Milan Netherlands
Novartis Investigative Site, Rotterdam, South Holland Novartis Investigative Site, Utrecht Poland
Novartis Investigative Site, Gdansk Novartis Investigative Site, Gliwice Novartis Investigative Site, Krakow Novartis Investigative Site, Poznan Novartis Investigative Site, Warsaw Novartis Investigative Site, Warsaw South Korea
Novartis Investigative Site, Seoul Novartis Investigative Site, Seoul Novartis Investigative Site, Seoul Spain
Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona Novartis Investigative Site, Oviedo, Principality of Asturias Novartis Investigative Site, Barcelona Novartis Investigative Site, Madrid Novartis Investigative Site, Madrid Novartis Investigative Site, Madrid Novartis Investigative Site, Salamanca United Kingdom
Novartis Investigative Site, Glasgow Novartis Investigative Site, London